NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000756

Registered date:01/07/2007

Candesartan may prevent aneurysmal changes in the residual native aorta after thoracic aortic aneurysm surgery

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedThoracic aortic aneurysm
Date of first enrollment2007/11/01
Target sample size150
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Administration of Cnadesartan Administration of antihypertensive drug other than Candesartan

Outcome(s)

Primary OutcomeChanges in the aortic diameter
Secondary OutcomePulse wave velocity

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients with contraindication for Candesartan Patients with allergic reaction to Candesartan Pregnant or potentially pregnant Patients who did not consent to the study Patients under 20 years of age Others who are not suitable to the enrollment from the physician's point of view

Related Information

Contact

public contact
Name Yoshikatsu Saiki
Address 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan Japan
Telephone 022-717-7222
E-mail ysaiki@mail.tains.tohoku.ac.jp
Affiliation Graduate School of Medicine, Tohoku University Department of Cardiovascular Surgery
scientific contact
Name Koichi Tabayashi
Address 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan Japan
Telephone 022-717-7222
E-mail konosuke.s@med.tohoku.ac.jp
Affiliation Graduate School of Medicine, Tohoku University Department of Cardiovascular Surgery